What clinical information is most useful to determine if SNM therapy is effective during a programming visit?

• A. Changes in device battery life.
• B. Lead impedance stability.
• C. Symptom reduction and improvements in quality-of-life measures during stimulation.
• D. Device size.

Answer: (C)

During an SNM programming visit, the most useful information is the patient’s actual symptom relief and quality-of-life improvement observed while stimulation is on. The therapy’s value hinges on real clinical response—fewer incontinence episodes, reduced urgency, or better daily functioning—so feedback from the patient about how they feel and how their symptoms change is the direct measure of effectiveness.

Hardware metrics like battery life, device size, or lead impedance stability tell you about the device’s status or integrity, not how well the stimulation is translating into symptom control. A device can appear functioning hardware-wise, yet the patient may still derive little or no symptomatic benefit, or vice versa. That’s why the observed clinical response during programming steps—the patient-reported relief and QoL improvements when stimulation is on—is the best indicator of whether SNM is working for them.